[Benign intracranial hypertension and ulcerative colitis].
Martín Rodríguez
M M
MM
Ruiz-Cabello Jiménez
M
M
Gómez García
M
M
Vega Villaamil
P
P
González Castillo
S
S
D000086:Acetazolamide / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000150:complications* / Q000188:drug therapy; D004172:Diplopia / Q000209:etiology; D004630:Emergencies; D005260:Female; D005500:Follow-Up Studies; D006261:Headache / Q000209:etiology; D006801:Humans; D019586:Intracranial Hypertension / Q000139:chemically induced / Q000175:diagnosis / Q000209:etiology*; D019804:Mesalamine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D002257:Carbonic Anhydrase Inhibitors; D019804:Mesalamine; D000086:Acetazolamide